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The exploration of novel chemical 
spaces is one of the most important 
tasks of cheminformatics when 
supporting the drug discovery 
process. Properly designed and 
trained deep neural networks can 
provide a viable alternative to brute-
force de novo approaches or various 
other machine-learning techniques 
for generating novel drug-like 
molecules. In this article we present 
a method to generate molecules 
using a long short-term memory 
(LSTM) neural network and provide an analysis of the results, including a virtual screening test. Using the network 
one million drug-like molecules were generated in 2 hours. The molecules are novel, diverse (contain numerous 
novel chemotypes), have good physicochemical properties and have good synthetic accessibility, even though these 
qualities were not specific constraints. Although novel, their structural features and functional groups remain closely 
within the drug-like space defined by the bioactive molecules from ChEMBL. Virtual screening using the profile QSAR 
approach confirms that the potential of these novel molecules to show bioactivity is comparable to the ChEMBL set 
from which they were derived. The molecule generator written in Python used in this study is available on request. 
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Introduction 
 
The exploration of novel chemical spaces is one of the most 
important tasks of cheminformatics in supporting drug 
discovery. One way to address this problem is a “brute 
force” approach, trying to enumerate all reasonable 
molecules within certain size constraints. Due to the 
combinatorial explosion of the number of possible molecules 
to be generated with increasing size, this approach is 
currently possible only for relatively small molecules. An 
example of this approach is the GDB-17 database 
containing 166 billion molecules [1]. Full enumeration, 
however, of molecules with 25-30 atoms (the average size 
of drug molecules) is currently not possible. One needs to 
utilize various sophisticated cheminformatics algorithms to 
sample representative chemical space to generate novel 
molecules of interest, for example combination of drug-like 
fragments, evolutionary algorithms or particle swarm 
optimization. Review [2] provides a good overview of 
molecule generating methods. 
Recent advances in neural networks has opened a new 
avenue for in silico generation of novel interesting 
molecules. Particularly the recently introduced long short-
term memory (LSTM) networks [3] are well suited for this 
purpose. The inner working of the LSTM network is quite 
complex and a detailed description is beyond the scope of 
this article. Simply speaking, thanks to their sophisticated 
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architecture, LSTM networks are able to “learn” 
characteristics of the objects they are trained on, and then 
answer questions about these objects and even generate 
new similar objects. LSTM networks have been used to 
support many new sophisticated technologies, including 
speech recognition, language translation, smart mobile 
phone assistants or self-driving cars [4]. Also numerous 
“lighter” applications that nicely document the power of the 
LSTM algorithm have been described. When trained on a 
set of Shakespeare’s plays the network was able to create 
novel “Shakespeare” sonnets [5], or when trained on some 
classical piano music, to compose new songs [6]. The 
characteristics described above make the LSTM recurrent 
neural network also a good candidate for cheminformatics 
applications and particularly for generation of novel chemical 
matter. 
  
The use of LSTM neural networks to generate novel 
molecules with desired properties is a hot topic and several 
academic as well as industrial groups are exploring this 
area. Bjerrum and Threlfall [7] used molecules from the 
ZINC database to train an LSTM network to generate novel 
molecules. Samples from these molecules have been 
checked using a retrosynthetic planning software and a 
retrosynthetic route could be identified for most of them. Use 
of several variations of training SMILES has been shown to 
provide better results than just a single canonical 
representation [8]. Gomez-Bombarelli et al. [9] trained an 
encoder-decoder network where the encoder was 
converting a molecule into a vector in a latent space, while 
the decoder was converting this vector back to the 
molecular structure. Operation in the continuous latent 
space allowed design of various drug-like molecules and 
light-emitting diodes. Olivecrona et al. [10] designed a 
network to generate molecules with desired properties, 
including analogues to a query structure and molecules with 
increased probability to be active again certain biological 
targets. Segler at al. [11] used molecules generated by an 
LSTM recurrent network to design several focused libraries 
targeting the serotonin receptor and several antibacterial 
targets. LSTM networks have also been successfully applied 
to retrosynthetic reaction prediction by Liu et al. [12], who 
trained a sequence-to-sequence reaction prediction network 
on 50,000 reactions from patents. The method performed 
comparably with a rule-based expert system. Yang et al. 
[13] combined a Monte Carlo tree search and a recurrent 
neural network to generate molecules with desired values of 
octanol-water partition coefficient and good synthesizability. 
Recently Gupta et al. [14] presented an application of 
recurrent networks for de novo drug design and fragment-
based drug discovery. During the submission process of this 
manuscript study of Popova et al. [24] appeared, describing 
computational strategy for de novo drug design based on 
deep and reinforced learning. 
Methodology 
 
Neural network architecture 
 
The open source high-level framework Keras [15] with the 
TensorFlow numerical backend engine [16] was used for 
this project. These popular software tools, written in Python, 
make development and application of deep neural networks 
relatively easy, allowing one to focus on the scientific 
aspects of the problem rather than on the details of 
numerical implementation. The major challenge in the 
application of LSTM networks is the design of a proper 
network architecture. The optimal combination of various 
network parameters (types and sizes of the network layers, 
activation and optimization functions, setting the learning 
and dropout rate and optimal way of encoding the training 
data into vectorised form required by the network) requires 
some trial and error. There are no general rules for 
designing the optimal architecture, one has to experiment 
and try different architectures and parameters. After several 
experiments the network architecture shown on Fig. 1 was 
selected for our study. 
 
 
Figure 1. The network architecture used in this study. 
 
The network consists of double LSTM layers (that actually 
learn the SMILES grammar) a dropout layer and an output 
dense layer with 23 neurons (the number of characters we 
want to predict probability for) with the softmax activation 
function. The default RMSProp optimizer was used for the 
training. During training, it was necessary to continually 
decrease the learning rate from 0.01 to 0.0002. When using 
the trained network to generate structures of novel 
molecules a certain level of randomness (as suggested in 
[17]) was added to get more diverse structures that do not 
too closely reproduce the molecules in the training set.  It is 
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worth restating that this architecture may not be optimal, but 
it is sufficient to produce good results (see below). 
 
Training data 
 
SMILES codes of 509,000 bioactive molecules (with activity 
on any target below 10 µm) from the ChEMBL database [18] 
were used to train the network. The SMILES codes were 
filtered and slightly modified to make the training easier. 
Only molecules containing the organic subset of atoms (H, 
C, N, O, S, P, F, Cl, Br, I) were used. Charged molecules 
were discarded and stereo information was not considered. 
Only molecules with up to 5 ring closures were retained in 
the training set. The atomic codes consisting of multiple 
characters (Cl, Br and [nH] in this case) were replaced by 
single character codes (L, R and A, respectively). After 
these modification the training corpus consisted of 23 
characters (atomic symbols with upper- and lowercase 
symbols representing the aliphatic and aromatic atoms, the 
= and # bond symbols, parentheses, numbers 1 to 5 
representing ring closures and a newline). The whole 
training corpus contained 23,664,668 characters. During the 
training process, sequences of 40 characters from the 
corpus were fed to the network together with a character 
following the sequence. The goal of the training was to learn 
this character from a preceding sequence. During the 
process the LSTM network learned the SMILES grammar 
and learned which character should most probably follow 
after certain group of characters. The Python code used to 
generate molecules in this study is available for download 
as an additional file. 
 
Results 
 
New SMILES codes were generated character-by-character 
using the trained LSTM neural network. Not all SMILES 
codes generated were fully grammatically correct. 
Therefore, as the first step we checked whether all brackets 
and ring closure numbers are paired. This test could be 
performed relatively fast as a simple text query without 
necessity to parse the SMILES. 54% of generated SMILES 
codes could be discarded in this test. An additional 14% 
were discarded during the full chemical parsing using RDKit 
[19] due to unrealistic aromatic systems or incorrect atomic 
valences. At the end, 32% of the generated SMILES strings 
led to correct molecules. The generation of one million 
correct molecules required less than 2 hours on 300 CPUs. 
Switching to GPUs and increasing the number of processors 
would allow generation of hundreds of millions or even 
billions of molecules over a weekend. 
The most important question we wanted to answer 
concerned the quality of generated molecules. Out of one 
million molecules generated, only 2774 were identical with 
molecules in the training ChEMBL set. The similarity 
distribution of the generated molecules to the ChEMBL 
compounds is shown in Fig. 2. The standard RDKit similarity 
based on Morgan fingerprints and Tanimoto coefficient was 
used [19]. One million generated structures contained 627 
thousand unique scaffolds (the scaffold is part of the 
molecule after removal of non-ring substituent, for molecules 
without rings it is the largest chain). For comparison the 
ChEMBL training set contained 172 thousand scaffolds. The 
overlap between the two sets was only 18 thousand 
scaffolds. These data illustrate that our protocol generates 
novel molecules and does not mirror the training set too 
closely. The generated molecules also have good 
properties. Calculated common molecular descriptors 
(molecular weight, logP and TPSA [20]) shown in Figure 3 
are very similar to those of the ChEMBL set.  
 
 
Figure 2. Similarity of molecules generated by the LSTM network to 
the ChEMBL training molecules 
 
. 
In Table 1, counts of the most important substructure 
features in the ChEMBL training set and the molecules 
generated by the LSTM network are shown. The table also 
contains a 3rd column showing statistics for molecules 
generated by a simple naive SMILES generator (denoted as 
baseline in the Table 1). By this analysis we wanted to see 
whether the “intelligence” of the deep LSTM neural network 
is necessary to generate valid molecules, or whether a 
simple SMILES generator using only the syntax of the 
SMILES language, and some basic statistics derived from a 
reference database of known structures is sufficient. This 
tool analyzed the training set to provide the frequencies of 
occurrence of atom types and the average number of 
symbols between pairing operations (ring closures and 
brackets). These were used as roulette wheel probabilities. 
SMILES generation started by picking an element according 
to frequency, and the string was then filled up character by 
character with symbols, rings and branches.  Aromatic 
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elements could only be added between ring closures.  At the 
end, the SMILES string was parsed using RDKit to see if it 
represents a valid molecule.  
This analysis clearly shows that the structures generated by 
the LSTM neural network have a distribution of substructure 
features very similar to those of the ChEMBL molecules, 
while the naive SMILES generator using only knowledge of 
the statistical distribution of characters in the SMILES 
strings and basic SMILES syntactic rules generates “ugly” 
molecules, mostly macrocycles and practically no fused 
aromatic systems, and is not able to reproduce the chemical 
space of the ChEMBL molecules. 
 
 
Figure 3. Calculated molecular properties and synthetic accessibility score for the ChEMBL training set and generated molecules. 
 
 
Table 1  
Comparison of substructure features between the ChEMBL training set, molecules generated by the LSTM network 
and by the naive SMILES generator. 
Feature ChEMBL generated baseline
no rings 0.4 0.4 0.1 
1 ring 2.8 4.3 13.2 
2 rings 14.8 23.1 17.7 
3 rings 32.2 43.5 27.3 
4rings 32.7 23.9 25.2 
>4 rings 17.2 4.8 16.5 
fused arom. rings 38.8 30.9 0.2 
large rings (> 8) 0.4 1.8 75.9 
spiro rings 1.9 0.6 0.6 
without N,O,S 0.0 0.2 2.6 
contains N 96.5 96.1 92.3 
contains O 93.0 92.0 85.5 
contains S 35.6 27.9 39.6 
contains halogen 40.7 38.8 49.4 
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Comparison of the most common functional groups [21] in 
both sets shown in Figure 4 indicates that both the ChEMBL 
molecules and the structures generated by the LSTM neural 
network have very similar distributions of functional groups, 
again confirming that both sets occupy the same chemical 
space. 
 
 
 
Figure 4. Comparison of the percentage of occurrences of the important functional groups in the ChEMBL training set (first number) and the 
generated molecules (second number). 
 
For both training and generated molecule sets, we also 
calculated the synthetic accessibility score [22], a measure 
of how easy it might be to synthesize the molecule. The 
distribution of the score (shown as the last graph in the 
Figure 2) is practically identical for both sets, indicating that 
the generated structures are of similar complexity as the 
drug-like molecules in the ChEMBL database. 
 
In summary, the generated structures are novel, having very 
little overlap with the training set, are diverse, containing 
large number of novel scaffolds, and their properties are in 
the same range as the drug-like ChEMBL molecules. The 
substructure analysis and the distribution of functional 
groups in the newly generated molecules indicates that the 
LSTM network is able to learn the drug-like structural 
features of the training set well and introduce them into the 
newly generated structures. 
 
Virtual screening 
 
The likelihood of the novel molecules showing bioactivity 
profiles comparable to the actual ChEMBL molecules was 
assessed by virtual screening. Profile-QSAR multi-target 
virtual screening models have been previously reported for  
 
 
Figure 5. Comparisons of predicted pIC50 cumulative 
frequency distributions between actual (blue) and generated 
(red) compounds for the 6 best ChEMBL kinase profile-QSAR 
models. All models had correlation between prediction and 
experiment of R2 > 0.75 for the very challenging “realistic” test 
sets. 
 
159 ChEMBL kinase assays [23]. Many of these models 
have very good prediction ability. Predictions from the top 
six models correlated with experiment with R2 > 0.75 on 
held-out test sets of the most novel possible compounds. 
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The activity of the actual ChEMBL structures and generated 
structures were predicted with these 6 models. Figure 5 
overlays the cumulative frequency distributions (CFD) of 
predicted pIC50 for the actual and generated ChEMBL 
compounds for these top 6 models. The overlays are almost 
perfect indicating that the generated compounds should 
have similar likelihoods of biological activity as the actual 
ChEMBL compounds.  
The Kolmogorov-Smirnov (KS) test quantitatively compares 
CFD curves by examining the largest vertical distance 
between the curves. The test was applied to random 
samplings of 1000 compounds from each model. Tee table 
2 shows the results of the KS test along with the means and 
standard deviations for the activity distributions of the actual  
and generated compounds for the 6 models. For 4 of the 6 
models, the KS test allows the null hypothesis that the 
distributions are the same with 95% confidence. For 2 of the 
assays, 809247 and 809170, the KS test rejects the null 
hypothesis that the distributions are the same with 95% 
confidence, but even in the worst case of 809170 the largest 
vertical distance is <10%. Within each assay, the pairs of 
means and standard deviations for the actual and generated 
distributions coincide very closely, much closer than the 
variation in the means and standard deviations between 
assays, indicating that the generated and actual compounds 
would have similar activity profiles. 
 
 
Table 2. Profile-QSAR Predicted Activity Distributions for 6 ChEMBL Assays 
Assay1 KS D2 Differ?3 Mean real4 Mean gen5 Stdev real6 Stdev gen7 
688395 6.01% no 4.66 4.69 0.25 0.24 
668624 3.60% no 4.86 4.86 0.25 0.24 
809226 9.90% yes 5.33 5.26 0.34 0.30 
809226 4.30% no 5.18 5.13 0.47 0.43 
688781 2.20% no 4.83 4.82 0.26 0.25 
809170 8.70% yes 5.12 5.07 0.51 0.46 
 
1 ChEMBL assay ID 
2 Kolmogorov Smirnov D statistic which is the maximum vertical distance between cumulative frequency distribution curves.  
3 Critical value of D at alpha=0.05 is 6.04%.If D>6.04% the distributions are different with 95% confidence.  
4 Mean predicted activity for real ChEMBL compounds 
5 Mean predicted activity for generated ChEMBL compounds 
6 Standard deviation of predicted activities for real ChEMBL compounds 
7 Standard deviation of predicted activities for generated ChEMBL compounds 
 
Conclusions 
 
The LSTM neural networks have been used to generate 
novel molecules based on a training set of 550 thousand 
drug-like molecules from the ChEMBL database. The 
generated structures are novel, diverse, have good 
properties and synthetic accessibility. Although novel, the 
molecules occupy the same area of chemical space as the 
known bioactive molecules. Virtual screening indicates 
that the generated molecules should have comparable 
probability of activity on various targets. 
The performance of the algorithm is sufficient to generated 
hundreds of millions, even billions of new drug-like 
molecules. Novel structures generated in this way may be 
used in virtual screening and in exploring novel interesting 
areas of the chemical universe. 
The Python code used to train the LSTM network and to 
generate SMILES codes of new molecules described in 
this article is available from the author (PE) on request. 
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